Accelerate your cytogenomics research for constitutional disorders and cancer. Access the sequencing power of the NextSeq 500 system, then confirm structural variants with complementary array technology.
Seamless transition from array scanning to sequencing
Perform next-generation sequencing (NGS) and cytogenomic microarray scanning all on one research instrument. The NextSeq 550 System combines high-quality array scanning with the proven and robust NextSeq 500 sequencing system. By leveraging array scanning on the NextSeq 550 System, researchers have instant access to a powerful, complementary technology to confirm copy number variants detected through sequencing.
Same high-quality, flexible sequencing power as the NextSeq 500 System
The NextSeq Series provides the flexible power and simplicity you need for transcriptome and targeted resequencing. With tunable output and exceptional data quality, the NextSeq Series offers a combination of high-throughput sequencing, flexibility, and accuracy, all at a cost that makes it just right for your lab.
Supports cytogenomic and karyomapping applications
The NextSeq 550 maximizes the menu of cutting-edge research applications, while minimizing instrument costs. The flexibility of the NextSeq 550 System enables a broad range of cytogenetics applications for reproductive, genetic health, and cancer research. Supported cytogenomic and karyomapping array products include:
BlueFuse Multi software provides molecular cytogenetic and in vitro fertilization (IVF) data analysis in a single framework. It offers a clear, intuitive user interface; a common workflow; and scales for the needs of your lab. This widely implemented software is used in over 150 clinical research laboratories globally and for more than 80% of the PGS cycles currently being screened.